208 related articles for article (PubMed ID: 22428079)
1. Enhanced protective efficacy of a chimeric form of the schistosomiasis vaccine antigen Sm-TSP-2.
Pearson MS; Pickering DA; McSorley HJ; Bethony JM; Tribolet L; Dougall AM; Hotez PJ; Loukas A
PLoS Negl Trop Dis; 2012; 6(3):e1564. PubMed ID: 22428079
[TBL] [Abstract][Full Text] [Related]
2. A multivalent chimeric vaccine composed of Schistosoma mansoni SmTSP-2 and Sm29 was able to induce protection against infection in mice.
Pinheiro CS; Ribeiro AP; Cardoso FC; Martins VP; Figueiredo BC; Assis NR; Morais SB; Caliari MV; Loukas A; Oliveira SC
Parasite Immunol; 2014 Jul; 36(7):303-12. PubMed ID: 24749785
[TBL] [Abstract][Full Text] [Related]
3. A phase 1 study of the safety, reactogenicity, and immunogenicity of a Schistosoma mansoni vaccine with or without glucopyranosyl lipid A aqueous formulation (GLA-AF) in healthy adults from a non-endemic area.
Keitel WA; Potter GE; Diemert D; Bethony J; El Sahly HM; Kennedy JK; Patel SM; Plieskatt JL; Jones W; Deye G; Bottazzi ME; Hotez PJ; Atmar RL
Vaccine; 2019 Oct; 37(43):6500-6509. PubMed ID: 31515141
[TBL] [Abstract][Full Text] [Related]
4. Protection and immunological study on two tetraspanin-derived vaccine candidates against schistosomiasis japonicum.
Chen L; Chen Y; Zhang D; Hou M; Yang B; Zhang F; Zhang W; Luo X; Ji M; Wu G
Parasite Immunol; 2016 Oct; 38(10):589-98. PubMed ID: 27189226
[TBL] [Abstract][Full Text] [Related]
5. A pilot study on developing mucosal vaccine against alveolar echinococcosis (AE) using recombinant tetraspanin 3: Vaccine efficacy and immunology.
Dang Z; Yagi K; Oku Y; Kouguchi H; Kajino K; Matsumoto J; Nakao R; Wakaguri H; Toyoda A; Yin H; Sugimoto C
PLoS Negl Trop Dis; 2012; 6(3):e1570. PubMed ID: 22479658
[TBL] [Abstract][Full Text] [Related]
6. Neutralizing antibodies to the hookworm hemoglobinase Na-APR-1: implications for a multivalent vaccine against hookworm infection and schistosomiasis.
Pearson MS; Pickering DA; Tribolet L; Cooper L; Mulvenna J; Oliveira LM; Bethony JM; Hotez PJ; Loukas A
J Infect Dis; 2010 May; 201(10):1561-9. PubMed ID: 20367477
[TBL] [Abstract][Full Text] [Related]
7. Schistosoma mansoni antigen Sm-p80: Prophylactic efficacy of a vaccine formulated in human approved plasmid vector and adjuvant (VR 1020 and alum).
Zhang W; Ahmad G; Torben W; Siddiqui AA
Acta Trop; 2011 May; 118(2):142-51. PubMed ID: 21334302
[TBL] [Abstract][Full Text] [Related]
8. Lipid core peptide targeting the cathepsin D hemoglobinase of Schistosoma mansoni as a component of a schistosomiasis vaccine.
Dougall AM; Skwarczynski M; Khoshnejad M; Chandrudu S; Daly NL; Toth I; Loukas A
Hum Vaccin Immunother; 2014; 10(2):399-409. PubMed ID: 24231271
[TBL] [Abstract][Full Text] [Related]
9. Prime-boost and recombinant protein vaccination strategies using Sm-p80 protects against Schistosoma mansoni infection in the mouse model to levels previously attainable only by the irradiated cercarial vaccine.
Ahmad G; Zhang W; Torben W; Haskins C; Diggs S; Noor Z; Le L; Siddiqui AA
Parasitol Res; 2009 Nov; 105(6):1767-77. PubMed ID: 19809833
[TBL] [Abstract][Full Text] [Related]
10. Inconsistent protective efficacy and marked polymorphism limits the value of Schistosoma japonicum tetraspanin-2 as a vaccine target.
Zhang W; Li J; Duke M; Jones MK; Kuang L; Zhang J; Blair D; Li Y; McManus DP
PLoS Negl Trop Dis; 2011; 5(5):e1166. PubMed ID: 21655308
[TBL] [Abstract][Full Text] [Related]
11. New tools for NTD vaccines: A case study of quality control assays for product development of the human hookworm vaccine Na-APR-1M74.
Pearson MS; Jariwala AR; Abbenante G; Plieskatt J; Wilson D; Bottazzi ME; Hotez PJ; Keegan B; Bethony JM; Loukas A
Hum Vaccin Immunother; 2015; 11(5):1251-7. PubMed ID: 26018444
[TBL] [Abstract][Full Text] [Related]
12. Sm-p80-based DNA vaccine formulation induces potent protective immunity against Schistosoma mansoni.
Ahmad G; Torben W; Zhang W; Wyatt M; Siddiqui AA
Parasite Immunol; 2009 Mar; 31(3):156-61. PubMed ID: 19222788
[TBL] [Abstract][Full Text] [Related]
13. A randomized, controlled Phase 1b trial of the Sm-TSP-2 Vaccine for intestinal schistosomiasis in healthy Brazilian adults living in an endemic area.
Diemert DJ; Correa-Oliveira R; Fraga CG; Talles F; Silva MR; Patel SM; Galbiati S; Kennedy JK; Lundeen JS; Gazzinelli MF; Li G; Hoeweler L; Deye GA; Bottazzi ME; Hotez PJ; El Sahly HM; Keitel WA; Bethony J; Atmar RL
PLoS Negl Trop Dis; 2023 Mar; 17(3):e0011236. PubMed ID: 36996185
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of the immune response and protective efficacy of Schistosoma mansoni Cathepsin B in mice using CpG dinucleotides as adjuvant.
Ricciardi A; Dalton JP; Ndao M
Vaccine; 2015 Jan; 33(2):346-53. PubMed ID: 25448114
[TBL] [Abstract][Full Text] [Related]
15. A Schistosoma japonicum chimeric protein with a novel adjuvant induced a polarized Th1 immune response and protection against liver egg burdens.
Xu X; Zhang D; Sun W; Zhang Q; Zhang J; Xue X; Shen L; Pan W
BMC Infect Dis; 2009 May; 9():54. PubMed ID: 19419545
[TBL] [Abstract][Full Text] [Related]
16. DNA Vaccine Encoding the Chimeric Form of Schistosoma mansoni Sm-TSP2 and Sm29 Confers Partial Protection against Challenge Infection.
Gonçalves de Assis NR; Batistoni de Morais S; Figueiredo BC; Ricci ND; de Almeida LA; da Silva Pinheiro C; Martins Vde P; Oliveira SC
PLoS One; 2015; 10(5):e0125075. PubMed ID: 25942636
[TBL] [Abstract][Full Text] [Related]
17. Schistosoma mansoni ex vivo lung-stage larvae excretory-secretory antigens as vaccine candidates against schistosomiasis.
El Ridi R; Tallima H
Vaccine; 2009 Jan; 27(5):666-73. PubMed ID: 19056448
[TBL] [Abstract][Full Text] [Related]
18. Protective effects of Sm-p80 in the presence of resiquimod as an adjuvant against challenge infection with Schistosoma mansoni in mice.
Ahmad G; Zhang W; Torben W; Noor Z; Siddiqui AA
Int J Infect Dis; 2010 Sep; 14(9):e781-7. PubMed ID: 20630783
[TBL] [Abstract][Full Text] [Related]
19. Differential protective impact of peptide vaccine formulae targeting the lung- and liver-stage of challenge Schistosoma mansoni infection in mice.
Tallima H; Tadros MM; El Ridi R
Acta Trop; 2024 Jun; 254():107208. PubMed ID: 38621620
[TBL] [Abstract][Full Text] [Related]
20. Role of antibodies in Sm-p80-mediated protection against Schistosoma mansoni challenge infection in murine and nonhuman primate models.
Torben W; Ahmad G; Zhang W; Siddiqui AA
Vaccine; 2011 Mar; 29(12):2262-71. PubMed ID: 21277404
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
